ExpreS2ion Biotech Holding AB (5JD0) Stock Price & Analysis

2 Followers

5JD0 Stock Chart & Stats

€0.06-€0.00(-1.64%)

At close: Nov 05 5:30 PM GMT+1

Day’s Range: EUR 0.06 - EUR 0.07
52-Week Range: EUR 0.03 - EUR 0.62
Previous Close: EUR 0.06
Volume: N/A
Average Volume (3M): 0
Market Cap: EUR 3.59M
Enterprise Value: EUR 22.17M
Total Cash (Recent Filing): EUR 34.38M
Total Debt (Recent Filing): EUR 1.45M
Price to Earnings (P/E): ―
Beta: 3.55
Next Earnings: Nov 12, 2026 (Est.)
EPS Estimate: N/A
Next Dividend Ex-Date: N/A
Dividend Yield: N/A

Bulls Say, Bears Say

Bulls Say

Proprietary Protein Expression Platform

The proprietary platform addresses technically difficult protein production, including complex viral antigens, which can support differentiation in vaccines and diagnostics. This capability may underpin recurring pharmaceutical, biotechnology, and academic customer work while enabling selected internal and collaborative programs.

Low Financial Leverage

Very low leverage limits the immediate burden of interest and refinancing obligations, giving the company more balance-sheet flexibility than a heavily indebted biotechnology peer. This provides room to manage development activity and pursue funding choices without substantial debt pressure.

Improving TTM Revenue

The reported TTM revenue increase indicates that commercial activity has improved relative to the prior annual period, offering a foundation for future operating leverage if growth can persist. Expansion across products, services, or programs could gradually improve the current revenue base.

Bears Say

Persistent Unprofitable Operations

Negative gross profit and sustained operating and net losses show that the current business model has not yet reached economic scalability. Unless revenue expands materially or costs decline, ongoing losses can constrain reinvestment, weaken capital efficiency, and require repeated external support.

Sustained Cash Burn

Materially negative operating and free cash flow means operations are consuming cash rather than funding themselves. The deterioration in free cash flow increases reliance on external financing and leaves less flexibility to support research, production, and commercial execution through the next several quarters.

Eroding Equity Base

Declining equity alongside strongly negative returns indicates that continuing losses are eroding the capital base. If funding needs persist, additional financing could create dilution risk, while the shrinking equity cushion may reduce resilience and limit the company’s ability to absorb further operating setbacks.

5JD0 FAQ

What was ExpreS2ion Biotech Holding AB’s price range in the past 12 months?

ExpreS2ion Biotech Holding AB lowest stock price was €0.03 and its highest was €0.62 in the past 12 months.

What is ExpreS2ion Biotech Holding AB’s market cap?

ExpreS2ion Biotech Holding AB’s market cap is €3.59M.

When is ExpreS2ion Biotech Holding AB’s upcoming earnings report date?

The company’s upcoming earnings report date is not yet available.

How were ExpreS2ion Biotech Holding AB’s earnings last quarter?

ExpreS2ion Biotech Holding AB released its earnings results on Aug 20, 2026. The company reported -€0.024 earnings per share for the quarter.

Is ExpreS2ion Biotech Holding AB overvalued?

Not enough analysts have published a price target to calculate whether the price is overvalued.

Does ExpreS2ion Biotech Holding AB pay dividends?

ExpreS2ion Biotech Holding AB does not currently pay dividends.

What is ExpreS2ion Biotech Holding AB’s EPS estimate?

ExpreS2ion Biotech Holding AB’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does ExpreS2ion Biotech Holding AB have?

ExpreS2ion Biotech Holding AB has 39,468,700 shares outstanding.

What happened to ExpreS2ion Biotech Holding AB’s price movement after its last earnings report?

ExpreS2ion Biotech Holding AB reported an EPS of -€0.024 in its last earnings report. Following the earnings report the stock price went up 10.345%.

Which hedge fund is a major shareholder of ExpreS2ion Biotech Holding AB?

Currently, no hedge funds are holding shares in DE:5JD0

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description